News
Bharat Biotech Says Its Covaxin Has Proven to Be Safe, Well-tolerated, and Immunogenic in ... - Latest Tweet by Prasar Bharati News Services
The latest Tweet by Prasar Bharati News Services states, 'Bharat Biotech says its Covaxin has proven to be safe, well-tolerated, and immunogenic in 2-18 years old volunteers in phase II/III study '
Bharat Biotech says its Covaxin has proven to be safe, well-tolerated, and immunogenic in 2-18 years old volunteers in phase II/III study
(File Pic) pic.twitter.com/y16dHtFFA2— Prasar Bharati News Services рдкреА.рдмреА.рдПрди.рдПрд╕. (@PBNS_India) December 30, 2021
(The above story first appeared on LatestLY on Dec 30, 2021 06:20 PM IST. For more news and updates on politics, world, sports, entertainment and lifestyle, log on to our website latestly.com).
